CoChat

Effects of exenatide therapy on insulin resistance in the skeletal muscles of high-fat diet and low-dose streptozotocin-induced diabetic rats

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Abstract

PURPOSE: The glucagon-like peptide (GLP)-1 agonist exenatide shows the same multiple effects on glucose homeostasis as native GLP-1, which can reduce blood glucose levels in individuals with type-2 diabetes mellitus (T2DM). However, its underlying action mechanism on glucose metabolism in the skeletal muscle of T2DM cases is unknown. We investigated the effects and action mechanisms of exenatide on insulin resistance (IR) in the skeletal muscle of high-fat diet and low-dose streptozotocin-induced T2DM rats. METHODS: Four groups of Sprague-Dawley rats were studied: non-T2DM (control, C); non-T2DM + exenatide (C + E); T2DM (D); and T2DM + exenatide (D + E). After eight weeks, isotope-tracer methodology was applied to measure the total rate of appearance (Ra) of glucose and glucose infusion rate (GIR) using a hyperinsulinemic-euglycemic clamp with 3-(3)H-glucose infusion. Glucose uptake in gastrocnemius muscles was determined by measuring 2-deoxy-D-(14)C-glucose radioactivity. Simultaneously, ultrastructural changes in the cells of gastrocnemius muscles were studied. RESULTS: In the D + E group, body weight and levels of fasting plasma glucose, triglyceride, total cholesterol, low-density lipoprotein and insulin were decreased significantly (p < 0.01) compared with the D group. The Ra of glucose (94.70 ± 13.46 versus 121.07 ± 16.55 μmol/kg/min) was decreased (p < 0.01), whereas the exogenous GIR (144.68 ± 11.03 versus 114.50 ± 9.40 μmol/kg/min) and glucose uptake in muscle (0.24 ± 0.02 versus 0.17 ± 0.02 μmol/g/min) were increased markedly (p < 0.01). Ultrastructural observations revealed that exenatide attenuated the effect of swollen mitochondrial and endoplasmic reticulum within the cells of the skeletal muscle of T2DM rats. CONCLUSIONS: These data suggest that exenatide can significantly improve insulin sensitivity in skeletal muscle by increasing glucose uptake in T2DM rats.

Overview

Integrity signals

Registry

Crossref · 10.3109/07435800.2015.1015726

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 26 references

Research works printed but not linked: 3

  1. DeFronzo RA, 1979, Am J Physiol, 237, E214
  2. DeFronzo RA, 1981, Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes, 30, 1000
  3. Arnés L, 2008, Int J Mol Med, 22, 127

Cited by

See all 16

Metadata

Authors
Wu, H., Sui, C., Xia, F., Zhai, H., Zhang, H., Xu, H., Weng, P., & Lu, Y.
Affiliations
Shanghai Jiao Tong University (CN)
Corresponding author
Lu, Yingli
Venue
Endocrine Research
Published
2015-09-11
Volume
41
Issue
1
Pages
1-7
ISSN
  • 0743-5800 (ISSN-L)
  • 1532-4206
OpenAlex
W1776504557
Cited by
15
References
26
Citations by year
2025: 3 · 2024: 1 · 2022: 1 · 2020: 2 · 2019: 2 · 2018: 1 · 2017: 2 · 2016: 2 · 2015: 1
FWCI
1.73
Type
journal article
Language
en
Open access
closed
Locations
  • Endocrine Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
Mayo Clinic
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
exenatide, GLP-1 receptor agonists, insulin resistance, skeletal muscle, type 2 diabetes, glucose uptake, glucose homeostasis, high-fat diet, streptozotocin-induced diabetes, mitochondrial swelling, endoplasmic reticulum, gastrocnemius, muscle ultrastructure, hyperinsulinemic-euglycemic clamp
MeSH terms
Exenatide, Animals, Blood Glucose, Diabetes Mellitus, Experimental, Insulin, Insulin Resistance, Male, Peptides, Streptozocin, Venoms, Rats, Sprague-Dawley, Muscle, Skeletal, Rats, Diet, High-Fat

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of exenatide therapy on insulin resistance in the skeletal muscles of high-fat diet and low-dose streptozotocin-induced diabetic rats. https://app.cochat.ai/papers/10.3109/07435800.2015.1015726
The paper
Wu, H., Sui, C., Xia, F., Zhai, H., Zhang, H., Xu, H., Weng, P., & Lu, Y. (2016). Effects of exenatide therapy on insulin resistance in the skeletal muscles of high-fat diet and low-dose streptozotocin-induced diabetic rats. Endocrine Research. https://doi.org/10.3109/07435800.2015.1015726

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.